Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2024 Filed Jul 18, 2024 00:01 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-080619 · tm2419709-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| July 15, 2024 Filed Jul 18, 2024 00:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-080616 · tm2419709-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,626 Underlying: Common Stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| July 15, 2024 Filed Jul 18, 2024 00:00 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,428 | $8.68 | $12,395.04 |
DisclosureSEC source: 0001104659-24-080616 · tm2419709-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,143 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| July 15, 2024 Filed Jul 18, 2024 00:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-080616 · tm2419709-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:02 UTC |
YARNO WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 49,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071373 · tm2417165-4_4seq1.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,303 Underlying: Common Stock · 49,303 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:03 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 49,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071374 · tm2417165-5_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,303 Underlying: Common Stock · 49,303 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:01 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 49,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071372 · tm2417165-3_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,303 Underlying: Common Stock · 49,303 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:00 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 49,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071370 · tm2417165-2_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,303 Underlying: Common Stock · 49,303 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:00 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 98,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071368 · tm2417165-1_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,607 Underlying: Common Stock · 98,607 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068773 · tm2416581-3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,346 Underlying: Common stock · 3,906 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,982 | $8.37 | $16,589.34 |
DisclosureSEC source: 0001104659-24-068773 · tm2416581-3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,486 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068773 · tm2416581-3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:04 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068771 · tm2416581-1_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,921 Underlying: Common stock · 10,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:04 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 4,426 | $8.37 | $37,045.62 |
DisclosureSEC source: 0001104659-24-068771 · tm2416581-1_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,325 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:04 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068771 · tm2416581-1_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:05 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068772 · tm2416581-2_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,613 Underlying: Common stock · 3,516 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:05 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,784 | $8.37 | $14,932.08 |
DisclosureSEC source: 0001104659-24-068772 · tm2416581-2_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,758 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:05 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068772 · tm2416581-2_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048428 · tm2412101-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,439 Underlying: Common stock · 2,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,427 | $11.89 | $16,967.03 |
DisclosureSEC source: 0001104659-24-048428 · tm2412101-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,562 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048428 · tm2412101-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:08 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048429 · tm2412101-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,504 Underlying: Common stock · 20,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:08 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 8,851 | $11.89 | $105,238.39 |
DisclosureSEC source: 0001104659-24-048429 · tm2412101-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,334 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:08 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048429 · tm2412101-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048427 · tm2412101-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,439 Underlying: Common stock · 2,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,427 | $11.89 | $16,967.03 |
DisclosureSEC source: 0001104659-24-048427 · tm2412101-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,026 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048427 · tm2412101-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:20 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031578 · tm248073-3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,252 Underlying: Common stock · 15,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:20 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 8,053 | $16.96 | $136,578.88 |
DisclosureSEC source: 0001104659-24-031578 · tm248073-3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,177 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:20 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 15,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031578 · tm248073-3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:19 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 41,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031576 · tm248073-2_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,338 Underlying: Common stock · 41,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:19 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 11,449 | $16.96 | $194,175.04 |
DisclosureSEC source: 0001104659-24-031576 · tm248073-2_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,351 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:19 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 41,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031576 · tm248073-2_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:17 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031575 · tm248073-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,129 Underlying: Common stock · 14,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:17 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 7,287 | $16.96 | $123,587.52 |
DisclosureSEC source: 0001104659-24-031575 · tm248073-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,641 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:17 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 14,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031575 · tm248073-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:58 UTC |
YARNO WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031115 · tm248017-11_4seq1.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031108 · tm248017-4_4seq1.xml · derivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,875 Underlying: Common stock · 46,875 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. F3 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 105,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031108 · tm248017-4_4seq1.xml · derivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,470 Underlying: Common stock · 105,470 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031113 · tm248017-9_4seq1.xml · derivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. F3 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031113 · tm248017-9_4seq1.xml · derivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common stock · 500,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Rothbaum Wayne P.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031114 · tm248017-10_4seq1.xml · derivative · entry 1 Rothbaum Wayne P. · CIK 0001423102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:55 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031112 · tm248017d8_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031111 · tm248017-7_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
MCPEAK MERRILL ADirector
|
GrantDeferred Restricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031110 · tm248017-6_4seq1.xml · derivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031109 · tm248017-5_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
BILINSKY IGORChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031107 · tm248017-3_4seq1.xml · derivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,875 Underlying: Common stock · 46,875 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. F3 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
BILINSKY IGORChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 105,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031107 · tm248017-3_4seq1.xml · derivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,470 Underlying: Common stock · 105,470 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Bellemin Jean-MarcChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031106 · tm248017-2_4seq1.xml · derivative · entry 2 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,875 Underlying: Common stock · 46,875 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. F3 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Bellemin Jean-MarcChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 105,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031106 · tm248017-2_4seq1.xml · derivative · entry 1 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,470 Underlying: Common stock · 105,470 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.